🔗 Share this article

A shadow economy for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and vendors on communication apps, according to new investigations.

Experimental Drug Acquiring Popularity Via Social Media

The experimental drug, which is still in research studies, is being advertised by social media influencers for its alleged weight-reducing effects. Followers are urged to contact these accounts directly for source information, while also obtaining promotional offers.

Thriving Commerce on Social Networks

Additionally, a flourishing market exists on messaging services, where communities with thousands of participants share “before and after” photos, injection guides and assertions of rapid UK delivery. Sellers market the drug there before directing customers to other platforms for transactions.

Learning About The Experimental Drug

Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.

Healthcare Experts Express Concerns

However, physicians and pharmacists have cautions that the distribution of what is still an unlicensed drug in the UK is worrisome and could result in users injecting substances of uncertain source.

Several professionals stated the demand for the experimental drug could be connected to the increasing price of approved weight loss treatments such as Mounjaro.

Legal Status and Implementation

Marketing the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Several content creators try to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still violate medicines, advertising, and consumer regulations, potentially leading to penalties, prosecution or prison.

Platform Reaction and Material Removal

According to the social media company, the platform has removed problematic content and banned associated keywords and search suggestions. The company said it was committed to keeping the platform secure and allocating resources in enhancing enforcement strategies.

Online Trading Activities

Research also found communities with up to nine thousand participants selling the experimental drug using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly brings up groups with numerous of users, filled with photos of slimming results, positive reviews and step-by-step guides for preparing or injecting at home.

Within minutes of entering one group, a vendor shared WhatsApp details, where most transactions take place. The vendor sent an instruction manual and guaranteed delivery within 48 hours. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None asked about body mass, medical conditions or previous experience.

Item Information and Costs

Within these groups, posts display dark colored parcels with postal service stickers, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at home with purified liquid, or pre-filled injectors typically sold at £160 for 20 milligrams. When asked how long a injector should be used, vendors give conflicting responses ranging from a several days to “depends on your body”.

Platform Moderation and Security Actions

A representative for the messaging service said it actively moderated harmful content on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting materials they cannot confirm. Although the research behind retatrutide is valid, these online versions may not contain what they claim,” said Jason Murphy, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to current price rises for approved slimming drugs such as Mounjaro. “With costs rising, patients are using online platforms. But fake injections are highly risky. You cannot know what’s contained or whether the conditions they were produced in was clean,” she explained.

Her staff has already seen patients harmed by self-injection from unconfirmed sources. “We recognize the disappointment, but buying from Telegram or communication platforms is taking chances with your health,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Statement

A spokesperson from Eli Lilly stated retatrutide was in phase 3 research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a company experimental substance not yet approved … may expose users to possibly serious health risks”.